Literature DB >> 21857824

Pancrelipase delayed-release capsules for the treatment of pancreatic insufficiency.

David C Whitcomb1.   

Abstract

Entities:  

Year:  2011        PMID： 21857824      PMCID： PMC3127028     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.

Authors:  David C Whitcomb; Glen A Lehman; Galina Vasileva; Ewa Malecka-Panas; Natalya Gubergrits; Yannan Shen; Suntje Sander-Struckmeier; Steven Caras
Journal:  Am J Gastroenterol       Date:  2010-05-25       Impact factor: 10.864

2.  A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.

Authors:  N Gubergrits; E Malecka-Panas; G A Lehman; G Vasileva; Y Shen; S Sander-Struckmeier; S Caras; D C Whitcomb
Journal:  Aliment Pharmacol Ther       Date:  2011-03-21       Impact factor: 8.171

Review 3.  Pancrelipase for pancreatic disorders: An update.

Authors:  R Dhanasekaran; P P Toskes
Journal:  Drugs Today (Barc)       Date:  2010-11       Impact factor: 2.245

Review 4.  Pancreatic enzyme replacement therapy in chronic pancreatitis.

Authors:  E C M Sikkens; D L Cahen; E J Kuipers; M J Bruno
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-06       Impact factor: 3.043

5.  Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.

Authors:  Bruce C Trapnell; Karen Maguiness; Gavin R Graff; David Boyd; Katrin Beckmann; Steven Caras
Journal:  J Cyst Fibros       Date:  2009-10-07       Impact factor: 5.482

6.  Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis.

Authors:  Gregory A Coté; Dhiraj Yadav; Adam Slivka; Robert H Hawes; Michelle A Anderson; Frank R Burton; Randall E Brand; Peter A Banks; Michele D Lewis; James A Disario; Timothy B Gardner; Andres Gelrud; Stephen T Amann; John Baillie; Mary E Money; Michael O'Connell; David C Whitcomb; Stuart Sherman
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 11.382

7.  13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis.

Authors:  J Enrique Domínguez-Muñoz; Julio Iglesias-García; María Vilariño-Insua; Marta Iglesias-Rey
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04       Impact factor: 11.382
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.